Literature DB >> 16484810

Cognitive impairment related to apathy in early Huntington's disease.

Sophie Baudic1, Patrick Maison, Guillaume Dolbeau, Marie-Françoise Boissé, Paolo Bartolomeo, Gianfranco Dalla Barba, Latchezar Traykov, Anne-Catherine Bachoud-Lévi.   

Abstract

OBJECTIVE: To investigate the relationships between cognitive impairment and apathy in patients with early Huntington's disease (HD) and to further explore the influence of depression on the outcome of cognitive changes associated with apathy.
METHODS: We included 36 early HD patients, among them 20 were apathetic (HDA) and 16 were not (HDnA). The two groups were matched by age, education and severity of disease. Cognitive functions were evaluated by a comprehensive neuropsychological battery that measures memory, attention, executive function, language and visuospatial abilities.
RESULTS: The HDA patients had significantly lower scores on memory, attention and executive function tests when compared with the HDnA patients (p values <0.05). We compared the performance of patients with (50%) and without depression on cognitive tasks and showed that depression per se did not influence performance. Finally, the results demonstrate that interactions between apathy and motor disturbance have a significant effect on cognitive impairment in HD. DISCUSSION: The presence of apathy is associated with more severe deficits of attention, executive function and episodic memory in early HD patients. Furthermore, the findings suggest that depression has little or no effect on cognitive deficits. Finally, apathy increased in parallel with both motor and cognitive dysfunction. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 16484810     DOI: 10.1159/000091523

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  18 in total

1.  "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.

Authors:  Kevin Duff; Jane S Paulsen; Leigh J Beglinger; Douglas R Langbehn; Chiachi Wang; Julie C Stout; Christopher A Ross; Elizabeth Aylward; Noelle E Carlozzi; Sarah Queller
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

Review 2.  Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects.

Authors:  Mohaddeseh Rahbaran; Angelina Olegovna Zekiy; Mahta Bahramali; Mohammadsaleh Jahangir; Mahsa Mardasi; Delaram Sakhaei; Lakshmi Thangavelu; Navid Shomali; Majid Zamani; Ali Mohammadi; Negin Rahnama
Journal:  Cell Mol Biol Lett       Date:  2022-07-16       Impact factor: 8.702

3.  Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease.

Authors:  Nora E Fritz; Nicholas R Boileau; Julie C Stout; Rebecca Ready; Joel S Perlmutter; Jane S Paulsen; Kimberly Quaid; Stacey Barton; Michael K McCormack; Susan L Perlman; Noelle E Carlozzi
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2018-03-21       Impact factor: 2.198

4.  Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease.

Authors:  Nigel I Wood; Valentina Carta; Stefan Milde; Elizabeth A Skillings; Catherine J McAllister; Y L Mabel Ang; Alasdair Duguid; Nadeev Wijesuriya; Samira Mohd Afzal; Joe X Fernandes; T W Leong; A Jennifer Morton; Jennifer Morton
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

5.  Multidimensional Apathy: The Utility of the Dimensional Apathy Scale in Huntington's Disease.

Authors:  Kelly J Atkins; Sophie C Andrews; Trevor T-J Chong; Julie C Stout
Journal:  Mov Disord Clin Pract       Date:  2021-02-12

6.  Negative symptoms in Huntington's disease.

Authors:  Paola Soliveri; Dominga Paridi; Francesca Del Sorbo; Irene Tramacere; Floriano Girotti
Journal:  Neurol Sci       Date:  2022-01-24       Impact factor: 3.307

7.  Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington's Disease.

Authors:  Maria B Misiura; Jennifer Ciarochi; Jatin Vaidya; Jeremy Bockholt; Hans J Johnson; Vince D Calhoun; Jane S Paulsen; Jessica A Turner
Journal:  J Int Neuropsychol Soc       Date:  2019-02-26       Impact factor: 2.892

8.  Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease.

Authors:  Patrick N Pallier; Elizabeth S Maywood; Zhiguang Zheng; Johanna E Chesham; Alexei N Inyushkin; Richard Dyball; Michael H Hastings; A Jennifer Morton
Journal:  J Neurosci       Date:  2007-07-18       Impact factor: 6.167

9.  Apathy is associated with executive functioning in first episode psychosis.

Authors:  Ann Faerden; Anja Vaskinn; Arnstein Finset; Ingrid Agartz; Elizabeth Ann Barrett; Svein Friis; Carmen Simonsen; Ole A Andreassen; Ingrid Melle
Journal:  BMC Psychiatry       Date:  2009-01-08       Impact factor: 3.630

10.  Neuropsychiatry and White Matter Microstructure in Huntington's Disease.

Authors:  Sarah Gregory; Rachael I Scahill; Kiran K Seunarine; Cheryl Stopford; Hui Zhang; Jiaying Zhang; Michael Orth; Alexandra Durr; Raymund A C Roos; Douglas R Langbehn; Jeffrey D Long; Hans Johnson; Geraint Rees; Sarah J Tabrizi; David Craufurd
Journal:  J Huntingtons Dis       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.